Drug
Rta 744
Rta 744: highest development phase Phase 1, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| RTA 744 NCT00526812 | Phase 1 | Glioma |
Latest
No recent events.
Follow Rta 744 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.